AR247398A1 - Procedimiento para preparar compuestos de de 7-(2-(5-amino-1,2,4-tiadiazol-3- il)-2-alcoxiimino-acetamido)-3-metil-imidazopir idio o imidazopiridazinio-3 cefem-4-carboxilato - Google Patents

Procedimiento para preparar compuestos de de 7-(2-(5-amino-1,2,4-tiadiazol-3- il)-2-alcoxiimino-acetamido)-3-metil-imidazopir idio o imidazopiridazinio-3 cefem-4-carboxilato

Info

Publication number
AR247398A1
AR247398A1 AR90316105A AR31610590A AR247398A1 AR 247398 A1 AR247398 A1 AR 247398A1 AR 90316105 A AR90316105 A AR 90316105A AR 31610590 A AR31610590 A AR 31610590A AR 247398 A1 AR247398 A1 AR 247398A1
Authority
AR
Argentina
Prior art keywords
amino
formula
tiadiazol
cefem
carboxylate
Prior art date
Application number
AR90316105A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1985/000102 external-priority patent/WO1986005184A1/ja
Priority claimed from NO851538A external-priority patent/NO165842C/no
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of AR247398A1 publication Critical patent/AR247398A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR COMPUESTOS DE 7-(2-(5-AMINO-1,2,4-TIADIAZOL-3- IL)-2-ALCOXIIMINO-ACETAMIDO)-3-METIL-IMIDAZOPIR IDIO O IMIDAZOPIRIDAZINIO-3 CEFEM-4-CARBOXILATO DE FORMULA (I), EN DONDE R1 ES AMINO O ALCANOIL AMINO, R3 ES HIDROGENO O ALQUILO,SUSTITUIDO O NO POR CIANO O CARBOXILO, SIENDO A + UN GRUPO IMIDAZOPIRIDAZINIO O IMIDAZOPIRIDINIO, SUSTITUIDO O NO POR HALOGENO, CIANO, ALQUILO, ALCOXI, DIALQUIL, AMINO, DIALQUIL, AMINO ALQUILO, ALQUILTIO, DIALQUIL, AMINO ALQUIL, TIO O AMINO Y LAS SALES Y ESTERES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS,QUE COMPRENDE HACER REACCIONAR UN COMPUESTO DE FORMULA (II), LAS SALES Y ESTERES DE LOS MISMOS, CON ACIDOS CARBOXILICOS DE FORMULA (III), EN LA QU R1' ES AMINO PROTEGIDO O NO Y R3' ES HIDROGENO O ALQUILO SUSTITUIDO O NO PORCN O CARBOXILO, PROTEGIDO O NO O SALES O DERIVADOS REACTIVOS DE LOS MISMOS.
AR90316105A 1985-03-01 1990-02-07 Procedimiento para preparar compuestos de de 7-(2-(5-amino-1,2,4-tiadiazol-3- il)-2-alcoxiimino-acetamido)-3-metil-imidazopir idio o imidazopiridazinio-3 cefem-4-carboxilato AR247398A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP1985/000102 WO1986005184A1 (en) 1985-03-01 1985-03-01 Antibacterial compound
NO851538A NO165842C (no) 1984-04-23 1985-04-17 Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
JP20932085 1985-09-20

Publications (1)

Publication Number Publication Date
AR247398A1 true AR247398A1 (es) 1994-12-29

Family

ID=27304712

Family Applications (1)

Application Number Title Priority Date Filing Date
AR90316105A AR247398A1 (es) 1985-03-01 1990-02-07 Procedimiento para preparar compuestos de de 7-(2-(5-amino-1,2,4-tiadiazol-3- il)-2-alcoxiimino-acetamido)-3-metil-imidazopir idio o imidazopiridazinio-3 cefem-4-carboxilato

Country Status (11)

Country Link
EP (1) EP0203271B1 (es)
JP (1) JPS62149682A (es)
CN (1) CN1030657C (es)
AR (1) AR247398A1 (es)
AU (1) AU598728B2 (es)
CA (1) CA1295995C (es)
DE (1) DE3688477T2 (es)
ES (3) ES8705892A1 (es)
NO (1) NO166283C (es)
NZ (1) NZ215333A (es)
WO (1) WO1986005183A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2519054B2 (ja) * 1986-06-09 1996-07-31 武田薬品工業株式会社 新規セフェム化合物
US4921851A (en) * 1986-06-09 1990-05-01 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use
DE3707019A1 (de) * 1987-03-05 1988-09-15 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
EP0304858A3 (en) * 1987-08-25 1989-12-20 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use
AU615966B2 (en) * 1987-12-04 1991-10-17 Takeda Chemical Industries Ltd. Crystals of cephem hydrochloride
US4933334A (en) * 1987-12-04 1990-06-12 Takeda Chemical Industries, Ltd. Antibiotic composition
PH27291A (en) * 1989-01-31 1993-05-04 Takeda Chemical Industries Ltd Imidazolpyrimidazines their production and use
EP0440119A1 (en) * 1990-01-31 1991-08-07 Takeda Chemical Industries, Ltd. Imidazopyridazine compounds, their production and use
EP0444549B1 (en) * 1990-03-01 1995-01-25 Takeda Chemical Industries, Ltd. Imidazopyridazines their production and use
JPH09110877A (ja) * 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
KR101655961B1 (ko) 2008-10-31 2016-09-08 시오노기세야쿠 가부시키가이샤 카테콜기를 갖는 세팔로스포린류
CN101735245A (zh) * 2008-11-05 2010-06-16 杨石 盐酸头孢唑兰及其中间体的制备方法
CN102070655B (zh) * 2009-11-23 2012-09-26 山东轩竹医药科技有限公司 含有咪唑环的头孢菌素衍生物
MX2012011521A (es) 2010-04-05 2013-03-08 Shionogi & Co Compuestos cefem que tienen un grupo catecol.
JP5852559B2 (ja) 2010-04-05 2016-02-03 塩野義製薬株式会社 擬似カテコール基を有するセフェム化合物
TWI547496B (zh) 2011-10-04 2016-09-01 葛蘭素集團公司 抗菌化合物
CN103570749A (zh) * 2013-11-15 2014-02-12 安徽悦康凯悦制药有限公司 一种头孢唑兰制备工艺
CN105153201B (zh) * 2015-08-29 2017-08-22 济南康和医药科技有限公司 一种盐酸头孢唑兰的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165430A (en) * 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
ES8306160A1 (es) * 1981-04-03 1983-05-01 Fujisawa Pharmaceutical Co "procedimiento para preparar un nuevo compuesto de cefem".
DE3247614A1 (de) * 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3336757A1 (de) * 1983-10-08 1985-04-25 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
NO165842C (no) * 1984-04-23 1991-04-17 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
PH22107A (en) * 1984-06-07 1988-06-01 Takeda Chemical Industries Ltd 3-pyrazolo(1,5-a)pyrdinium cephem compounds

Also Published As

Publication number Publication date
JPS62149682A (ja) 1987-07-03
DE3688477T2 (de) 1993-09-16
DE3688477D1 (de) 1993-07-01
ES8801289A1 (es) 1988-01-01
ES8705892A1 (es) 1987-05-16
NO860725L (no) 1986-09-02
EP0203271A2 (en) 1986-12-03
JPH0257074B2 (es) 1990-12-03
EP0203271B1 (en) 1993-05-26
AU5416886A (en) 1986-09-04
EP0203271A3 (en) 1988-06-01
ES557182A0 (es) 1988-01-01
ES557183A0 (es) 1988-01-01
NZ215333A (en) 1988-09-29
CA1295995C (en) 1992-02-18
NO166283C (no) 1991-06-26
WO1986005183A1 (en) 1986-09-12
AU598728B2 (en) 1990-07-05
NO166283B (no) 1991-03-18
ES8801290A1 (es) 1988-01-01
ES552525A0 (es) 1987-05-16
CN1030657C (zh) 1996-01-10
CN86102034A (zh) 1987-01-07

Similar Documents

Publication Publication Date Title
AR247398A1 (es) Procedimiento para preparar compuestos de de 7-(2-(5-amino-1,2,4-tiadiazol-3- il)-2-alcoxiimino-acetamido)-3-metil-imidazopir idio o imidazopiridazinio-3 cefem-4-carboxilato
AR240830A2 (es) Procedimiento para preparar derivados de acidos naftiridin quinolin-y benzoxazincarboxilicos.
BR9401482A (pt) 1H-Indol-3-acetamida, formulação farmacêutica, utilização de um composto e processo para a preparação de 1h-indol-3-acetamida
PH19270A (en) 2 azaspiro(4.(3+n)alkane 3-carboxylic acid derivatives
PT82149B (pt) Processo para a preparacao de derivados de pirido{2,3-d}pirimidina
AR241532A1 (es) Procedimiento para preparar nuevos derivados de acido-tiazolidin-4(s)-carboxilico.
DK0389984T3 (da) Carbonatderivater af Eserolin, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
AR241463A1 (es) Procedimiento para preparar aza derivados de piperiliden cicloheptenos, y procedimiento para preparar composiciones farmaceuticas utiles.
PT96175A (pt) Processo para a preparacao de acidos oxoftalazinil acetico substituidos e seus analogos
DK0589322T3 (da) 5-Oxo-dibenzo a,d cyclohepta-1,4-diener samt deres anvendelse som retrovirale midler.
KR880013885A (ko) 비사이클 설폰아미드 유도체 및 그의 제조방법
NO871575L (no) Fremgangsmaate for fremstilling av 1,5-benztiazepin-derivater.
EG19154A (en) Antiviral highly water soluble, stable, cujstaline salts of 2,3 dideoxyinosine monohydrate,2,3 dideoxy 2,3 didehydrothumidine monohydrate and 2,3 - dideoxy-2- fluoroinosine hemilydrate
FI861238A0 (fi) Foerfarande foer framstaellning av kinolin-3-karboxylsyror.
HK1005732A1 (en) Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
MX9100450A (es) Reduccion de niveles de acido urico en la sangre
ATE79625T1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4b>indol-1-essigs|uren.
AR005454A1 (es) Derivados de isooxacefem, su uso, procedimiento para su preparacion y preparaciones farmaceuticas que contienen a dichos derivados.
HU9302786D0 (en) New thiophene-2-carboxylic acid derivatives and process for preparing them
IE893533L (en) Substituted 3-aminosydnonimines, processes for their¹preparation and their use
BR9810031A (pt) Derivados de ácido pirrolidina carboxìlico como antagonistas á endotelina
ES542675A0 (es) Un procedimiento para preparar compuestos de cefalosporina
ATE170187T1 (de) Pyrrolothienopyrazin-verbindungen als 5ht3- rezeptoren-antagonisten
GT199400068A (es) Derivados de cefalosporina